(Int J Audiol[TA])
3,048 results
  • The NAL-NL3 Prescription. [Journal Article]
    Int J Audiol. 2026 Oct 22; :1-23. [Online ahead of print]Kitterick PT, Monaghan JJM, … Edwards BIJ
  • CONCLUSIONS: The NAL-NL3 Prescription retains NAL's validated approach to prescribing gain and compression while generating targets with higher predicted intelligibility that are clinically appropriate for a wider range of fittings.
  • A device-independent approach to cochlear-implant telehealth. [Journal Article]
    Int J Audiol. 2026 Oct 08; :1-21. [Online ahead of print]Bernstein JGW, Pillion EM, … Tolisano AMIJ
  • CONCLUSIONS: Combining a manufacturer-independent headphones-based alternative to sound-field testing with manufacturer's programming software in a remotely controlled laptop system replicates sound-field outcome scores and produces high patient satisfaction.
  • Hearing-aid outcomes in adults with subjective listening difficulties in noise despite normal audiograms. [Journal Article]
    Int J Audiol. 2026 Oct 04; :1-16. [Online ahead of print]Shin J, Dillon HIJ
  • CONCLUSIONS: Hearing aids were associated with statistically significant and clinically meaningful improvements in speech-in-noise performance in adults with subjective listening difficulties and heterogeneous auditory-processing profiles. Apparent variability in aided benefit should be interpreted cautiously, as it likely reflects both measurement variability and true inter-participant differences. The broad consistency in benefit was observed despite marked differences in participants' baseline characteristics across multiple dimensions.